Use of Non-Contrast-Enhanced MR Angiography to Assess Recanalization after Uterine Artery Embolization.
Juliana Yumi IshisakiHitomi KatoYoshiki KuwatsuruHiroshi ToeiAyako HoshinaNaoki TakemasaMasafumi AraiRyohei KuwatsuruPublished in: Journal of clinical medicine (2023)
The purpose of this study was to examine the use of non-contrast-enhanced MR angiography (MRA) for assessing recanalization of uterine arteries (UAs) after uterine artery embolization (UAE) for symptomatic fibroids. Pre-procedural and follow-up unenhanced MRA images of 30 patients were reviewed, and the extent to which the UAs could be visualized was classified on a 4-point scale. An increase in the score between consecutive time points indicates that a previously inconspicuous segment of the UA became visible on follow-up images. Patients were divided into two groups according to the presence (or absence) of recanalization. The median UA visualization score at each follow-up was significantly lower than that at baseline ( p < 0.01), but there was no significant difference between the scores of the follow-up images. Recanalization was detected in 63% (19/30) of patients. In these patients, the mean decrease in uterine and largest fibroid volume at 12 months after UAE was inferior to the mean decrease in patients for whom recanalization was not detected. Based on MRA assessment, recanalization after UAE occurred in 63% of patients but did not compromise the reduction in uterine and dominant fibroid volumes within 12 months after UAE.
Keyphrases
- end stage renal disease
- contrast enhanced
- ejection fraction
- chronic kidney disease
- newly diagnosed
- magnetic resonance imaging
- computed tomography
- magnetic resonance
- prognostic factors
- optical coherence tomography
- patient reported outcomes
- deep learning
- middle cerebral artery
- machine learning
- endovascular treatment